LCD ID Number: L37822 Status: A-Approved
LCD Title: MolDX: Breast Cancer Index® (BCI) Gene Expression Test
Geographic Jurisdiction: Nevada Other Jurisdictions
Original Determination Effective Date:
04/16/2019
Original Determination Ending Date:
Revision Effective Date:
10/28/2021
Revision End Date:
CMS National Coverage Policy:
Title XVIII of the Social Security Act (SSA), §1862(a)(1)(A), states that no Medicare payment shall be made for items or services that are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member. 42 CFR §410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions. CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests, §80.1.1 Certification Changes
Sorry, you need to login or register to view additional sections of this Medicare policy.
*
|